POLICY BRIEFINGS


Upcoming Congressional Meetings and Hearings


House Appropriations Labor, Health and Human Services, Education, and Related Agencies Subcommittee: hearing on proposed fiscal year 2016 appropriations for the National Institutes of Health (NIH); a list of witnesses can be found here; 10:00 a.m., 2358-C Rayburn Bldg.; Mar. 3

House Appropriations Agriculture, Rural Development, FDA, and Related Agencies Subcommittee: hearing on proposed fiscal year 2016 appropriations for the Food and Drug Administration (FDA); a list of witnesses can be found here; 10:00 a.m., 2362-A Rayburn Bldg.; Mar. 4

Senate Health, Education, Labor and Pensions Committee: hearing titled “America’s Health IT Transformation: Translating the Promise of Electronic Health Records Into Better Care;” 10:00 a.m., 430 Dirksen Bldg.; Mar. 5

House Energy and Commerce Health Subcommittee: hearing titled “Examining the 340B Drug Pricing Program;” 10:00 a.m., 2123 Rayburn Bldg.; Mar. 5


Health Legislation Recently Introduced


S. 531 (HEALTH INSURANCE), to permit health insurance issuers to offer additional plan options to individuals; FLAKE; to the Committee on Finance; Feb. 23

H.R. 1021 (MEDICARE INTEGRITY), to amend title XVIII of the Social Security Act to improve the integrity of the Medicare program, and for other purposes; BRADY; jointly, to the committees on Ways and Means and Energy and Commerce; Feb. 24

S. 536 (IHS), to amend the Internal Revenue Code of 1986 to exclude from gross income payments under the Indian Health Service Loan Repayment Program and certain amounts received under the Indian Health Professions Scholarship Program; UDALL; to the Committee on Finance; Feb. 24

S. 539 (OUTPATIENT REHABILITATION), to amend title XVIII of the Social Security Act to repeal the Medicare outpatient rehabilitation therapy caps; CARDIN; to the Committee on Finance; Feb. 24

H.R. 1055 (ORAL HEALTH), to improve access to oral health care for vulnerable and underserved populations; CUMMINGS; jointly, to the committees on Energy and Commerce, Ways and Means, the Judiciary, Natural Resources, Veterans’ Affairs, and Armed Services; Feb. 25

H.R. 1066 (CLINICAL TRIALS), to amend the Federal Food, Drug, and Cosmetic Act to promote the use of adaptive trial designs, Bayesian methods, and other innovative statistical methods in clinical protocols for drugs, biological products, and devices, and with respect to the requirement to conduct postapproval studies and clinical trials, and for other purposes; COLLINS; to the Committee on Energy and Commerce; Feb. 25



March 2, 2015: | Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7

SERVICES




BRIEFING ARCHIVE


 -  2018


 +  2017


 +  2016


 +  2015


 +  2014


 +  2013


 +  2012


 +  2011